ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
The impact of non-centralised surgical treatment on local recurrence, amputation rate and survival in patients with extremity soft tissue sarcoma.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the outcomes of surgical treatment for extremity soft tissue sarcomas in a country without a legislatively designated sarcoma center and to assess the impact of non-centralized surgical care on local recurrence, amputation rates, and patient survival.
methodsA total of 97 patients treated over a five-year period at our orthopedic oncology unit, with a minimum follow-up of 24 months, were included. Patients were stratified into four groups according to the time point at which they were referred from regional hospitals to our department (before biopsy, after biopsy, after resection, and after local recurrence). Using descriptive statistics, we compared local recurrence rates, amputation rates, and overall survival among these groups.
resultsPatients who were both diagnosed and initially operated on at the specialized orthopedic oncology unit had a substantially lower local recurrence rate (13.8%, CI [0.04, 0.23]. vs. 33.3–53.8%, CI [0.12, 0.72]) and a higher 24-month overall survival rate (80.5%, CI [0.67, 0.93] vs. 46.1–71.4%, CI [0.27, 0.90]) compared with those whose initial management occurred at regional facilities. Amputation rates varied between groups, with the lowest rate observed in patients diagnosed and treated at the specialized unit (2.8%, CI [0, 0.07] vs. 7.1–19.2%, CI [0, 0.36]); however, these differences did not reach statistical significance.
conclusionThese findings are consistent with previously published data and support the centralization of care for extremity soft tissue sarcomas, which is associated with lower local recurrence and improved survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.